BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Activity
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

25 hedge funds and large institutions have $31.9M invested in Bellerophon Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-5
Holders Change %
-16.67%
% of All Funds
0.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
7
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
1
Bridgeway Capital Management
Texas
$147K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.01M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$186K
4
VF
4
Virtu Financial
New York
$29K
5
ARTA
5
A.R.T. Advisors
New York
$24K

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$584K
3
TI
3
Telemetry Investments
New York
$0
4
Creative Planning
4
Creative Planning
Kansas
$0
5
TSS
5
Two Sigma Securities
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Creative Planning
26
Creative Planning
Kansas
– -$49K -3,034 Closed
TSS
27
Two Sigma Securities
New York
– -$30K -1,823 Closed
CIBC Private Wealth Group
28
CIBC Private Wealth Group
Georgia
– -$14K -833 Closed
Jane Street
29
Jane Street
New York
– -$12K -741 Closed
Bank of America
30
Bank of America
North Carolina
– -$3K -214 Closed
1
2